H1 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: KEYMED BIO-B(02162) the Revenue is 712.18 M (--%), Beat estimate;the EBIT is -166.61 M (--%), Beat estimate;the EPS is 4.91 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.71B--
0.71B--
+0.00B--%
EBITExceed expectations
-0.17B--
-0.26B--
+0.10B--%
EPSMiss expectations
4.9051--
5.309--
-0.4039--%
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf